Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 9

1.

Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate.

Tolmachev V, Feldwisch J, Lindborg M, Baastrup B, Sandström M, Orlova A.

Nucl Med Biol. 2011 Jul;38(5):697-706. doi: 10.1016/j.nucmedbio.2010.11.013. Epub 2011 Mar 3.

PMID:
21718945
2.

Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.

Capala J, Bouchelouche K.

Curr Opin Oncol. 2010 Nov;22(6):559-66. doi: 10.1097/CCO.0b013e32833f8c3a. Review.

4.

Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.

Löfblom J, Feldwisch J, Tolmachev V, Carlsson J, Ståhl S, Frejd FY.

FEBS Lett. 2010 Jun 18;584(12):2670-80. doi: 10.1016/j.febslet.2010.04.014. Epub 2010 Apr 11. Review.

5.

Design of an optimized scaffold for affibody molecules.

Feldwisch J, Tolmachev V, Lendel C, Herne N, Sjöberg A, Larsson B, Rosik D, Lindqvist E, Fant G, Höidén-Guthenberg I, Galli J, Jonasson P, Abrahmsén L.

J Mol Biol. 2010 Apr 30;398(2):232-47. doi: 10.1016/j.jmb.2010.03.002. Epub 2010 Mar 10.

PMID:
20226194
6.

A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue.

Tolmachev V, Velikyan I, Sandström M, Orlova A.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1356-67. doi: 10.1007/s00259-009-1367-7. Epub 2010 Feb 4.

PMID:
20130858
7.

Imaging of HER-2 overexpression in tumors for guiding therapy.

Tolmachev V.

Curr Pharm Des. 2008;14(28):2999-3019. Review.

PMID:
18991715
8.

Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers.

Wållberg H, Orlova A.

Cancer Biother Radiopharm. 2008 Aug;23(4):435-42. doi: 10.1089/cbr.2008.0464.

PMID:
18771347
9.

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.

Orlova A, Tolmachev V, Pehrson R, Lindborg M, Tran T, Sandström M, Nilsson FY, Wennborg A, Abrahmsén L, Feldwisch J.

Cancer Res. 2007 Mar 1;67(5):2178-86.

Supplemental Content

Support Center